Key Elements in Greater Philadelphia Will Power Continued Growth Among Life Sciences and Cell and Gene Therapy Companies
Here is where Greater Philadelphia stands – and where it’s going – when it comes to the economic essentials that companies seek.
New Office of Transformation and Opportunity to Spur Growth and Innovation in Pennsylvania
This newly created office, signed into action via executive order by Governor Josh Shapiro, will be a resource for businesses, particularly in often neglected communities, looking to grow and will work to reignite Pennsylvania’s economy.
Gattuso Secures $290M Construction Loan to Develop Life Sciences Building on Drexel Campus
The 11-story, 520,000-square-foot building, which will be constructed atop Drexel’s recreation field, will be the largest life sciences research and lab space in the city once completed in 2024.
Polysciences Announces New Bioprocessing Brand
The new brand, Kyfora Bio, will represent its product offerings to the bioprocessing market and focus on the synthesis of materials used in nucleic acid delivery for cell and gene therapies.
National Institute for Innovation in Manufacturing Biopharmaceuticals Receives $15 Million in Federal Earmarks for Expansion
The SABRE Center, which will be built on the University of Delaware’s STAR Campus, will be a so-called current Good Manufacturing Practices (cGMP) facility that will support biopharmaceutical innovation for clinical research.
D2 Organization Planning to Build Three Philadelphia-Area Class A Warehouses
The three warehouses, totaling 586,000 square feet of logistic space, will be located at the renamed Salem Commerce Park in Carneys Point, N.J.